WHO sees the benefits of the AstraZeneca vaccine outweigh the risks at the moment, WHO said in a statement. Therefore, WHO recommends that the implementation of this vaccine vaccination continues to be carried out.
WHO is maintaining close communication with the European Pharmaceutical Regulatory Authority and other pharmaceutical regulators around the world to keep up with the latest information on the safety of the AstraZeneca vaccine. The WHO Global Advisory Committee on Vaccine Safety is also cautiously reviewing the latest vaccine safety data and will immediately make it available to the public once the review is finalized.
The WHO emphasizes that vaccination against Covid-19 does not reduce the risk of other illness or death from other causes. According to the WHO, the phenomenon of thrombosis (blood clots) is believed to occur frequently and is the third most common cardiovascular disease globally. In immunization programs, countries often report possible post-vaccination side effects, but this does not necessarily mean that they are related to the vaccination. However, it is still a “good practice” to investigate.
The statements made by WHO in the context of some countries around the world decide to suspend the use of the AstraZeneca vaccine due to fears of side effects causing venous thrombosis. On the pharmaceutical side AstraZeneca, they said that there is no basis to confirm their vaccine causes this blood clotting problem.